Successful Heart Transplantation Following Decompressive Craniectomy in a Patient with Restrictive Cardiomyopathy and Extensive Stroke in the Region of the Right Middle Cerebral Artery
DOI:
https://doi.org/10.3889/oamjms.2014.084Abstract
Restrictive cardiomyopathy (RCM) in children is associated with a greater risk of embolic stroke than are other congenital heart diseases. After diagnosis, 50% of children with RCM die within 2 years without heart transplantation. As such, all RCM patients are placed on the heart transplantation list and must wait for an appropriate heart for transplantation. Every type of embolic stroke can occur while waiting for a donor heart; therefore, the cardiovascular team must initiate antithrombotic therapy at time RCM is diagnosed. Some pediatric RCM patients experience embolic stroke (50% are the cerebral type) despite antithrombotic therapy, including acetylsalicylic acid, warfarin, and heparine. Neurosurgeons working in hospitals that perform organ transplantation expect to see RCM cases with restrictive large cerebral infarct. We think that decompressive craniectomy should be performed as soon as possible after determining the clinical condition of any patient with RCM and a large right middle cerebral artery (MCA) infarct.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Denfield SW, Webber SA. Restrictive cardiomyopathy in childhood. Heart Fail Clin. 2010; 6:445–452. DOI: https://doi.org/10.1016/j.hfc.2010.05.005
Maron BJ, Towbin JA, Thiene G., et. al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113:1807–1816. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.174287
Chen SC, Balfour IC, Jureidini S. Clinical spectrum of restrictive cardiomyopathy in children. J Heart Lung Transplant. 2001; 20:90–92. DOI: https://doi.org/10.1016/S1053-2498(00)00162-5
Cetta F, O’Leary PW, Seward JB, Driscoll DJ. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 1995; 70:634–640. DOI: https://doi.org/10.4065/70.7.634
Denfield SW, Rosenthal G, Gajarski RJ, Bricker JT, Schowengerdt KO, Price JK, et al. Restrictive cardiomyopathies in childhood. Etiologies and natural history. Tex Heart Inst J. 1997; 24:38–44.
Gewillig M, Mertens L, Moerman P, Dumoulin M. Idiopathic restrictive cardiomyopathy in childhood. A diastolic disorder characterized by delayed relaxation. Eur Heart J. 1996;17:1413–1420. DOI: https://doi.org/10.1093/oxfordjournals.eurheartj.a015076
Weller RJ, Weintraub R, Addonizio LJ, Chrisant MRK, Gersony WM, Hsu DT. Outcome of idiopathic restrictive cardiomyopathy in children. Am J Cardiol. 2002;90:501–506. DOI: https://doi.org/10.1016/S0002-9149(02)02522-5
Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J. 1992; 123:1589–93. DOI: https://doi.org/10.1016/0002-8703(92)90814-C
Neudorf U, Bolte A, Lang D, Hentrich F, Schmaltz A. Diagnostic findings and outcome in children with primary restrictive cardiomyopathy. Cardiol Young. 1996; 6:44–7. DOI: https://doi.org/10.1017/S1047951100003231
Beslow LA, Licht DJ, Smith SE, Storm PB, Heuer GG, Zimmerman RA, et al. Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke. 2010;41:313–318. DOI: https://doi.org/10.1161/STROKEAHA.109.568071
Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004; 35:539–543. DOI: https://doi.org/10.1161/01.STR.0000109772.64650.18
Smith SE, Kirkham FJ, Deveber G, Millman G, Dirks PB, Wirrell E, et al. Outcome following decompressive craniectomy for malignant middle cerebral infarction in children. Dev Med Child Neurol. 2011;53:29–33. DOI: https://doi.org/10.1111/j.1469-8749.2010.03775.x
Burak CR, Bowen MD, Barron TF. The use of enoxaparin in children with acute, nonhemorrhagic stroke. Pediatr Neurol. 2003;29:295–298. DOI: https://doi.org/10.1016/S0887-8994(03)00270-4
Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians evidenced-based clinical practice guidelines 8th ed. Chest. 2008; 133:887–968. DOI: https://doi.org/10.1378/chest.08-0762
Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children. A scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39: 2644–2691. DOI: https://doi.org/10.1161/STROKEAHA.108.189696
Schechter T, Kirton A, Laughlin S, Pontigon AM, Finkelstein Y, MacGregor D, et al. Safety of anticoagulants in children with arterial ischemic stroke. Blood. 2012;119:949–956. DOI: https://doi.org/10.1182/blood-2011-06-361535
Sträter R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke. 2001;32:2554–2558. DOI: https://doi.org/10.1161/hs1101.097379
Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics. 1998;101:369–376. DOI: https://doi.org/10.1542/peds.101.3.369
Gunthard J, Stocker F, Bolz D, Jaggi E, Ghisla R, Oberhansli I, et al. Dilated cardiomyopathy and thrombo-embolism. Eur J Pediatr. 1997;156:3–6. DOI: https://doi.org/10.1007/s004310050541
John JB, Cron SG, Kung GC, Mott AR. Intracardiac thrombi in pediatric patients: presentation profiles and clinical outcomes. Pediatr Cardiol. 2007; 28:213–220. DOI: https://doi.org/10.1007/s00246-005-1068-3
McCrindle BW, Karamlou T, Wong H, Gangam N, Trivedi KR, Lee KJ, et al. Presentation, management and outcomes of thrombosis for children with cardiomyopathy. Can J Cardiol. 2006;22:685–690. DOI: https://doi.org/10.1016/S0828-282X(06)70937-0
Amlie-Lefond C, de Veber G, Chan A, International Pediatric Stroke Study et al. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 2009; 8:530–536. DOI: https://doi.org/10.1016/S1474-4422(09)70106-1
Bigi S, Fischer U, Wehrli E, Mattle HP, Boltshauser E, Burki S, et al. Acute ischemic stroke in children versus young adults. Ann Neurol. 2011;70:245–254. DOI: https://doi.org/10.1002/ana.22427
Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke. 2007; 38:1850–1854. DOI: https://doi.org/10.1161/STROKEAHA.106.473983
McKenna A, Wilson CF, Caldwell SB, Curran D. Functional outcomes of decompressive hemicraniectomy following malignant middle cerebral artery infarctions: a systematic review. Br J Neurosurg. 2012;26(3):310-5. DOI: https://doi.org/10.3109/02688697.2012.654835
McKenna A, Wilson FC, Caldwell S, Curran D, Nagaria J, Convery F. Long-term neuropsychological and psychosocial outcomes of decompressive hemicraniectomy following malignant middle cerebral artery infarctions. Disabil Rehabil. 2012; 34(17):1444-55. DOI: https://doi.org/10.3109/09638288.2011.644024
Rahme R, Zuccarello M, Kleindorfer D, Adeoye OM, Ringer AJ. Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction: is life worth living? J Neurosurg. 2012;117(4):749-54. DOI: https://doi.org/10.3171/2012.6.JNS111140
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
